Home

Current Issue

Archives

Guidelines for Authors and Reviewers

Classified Ads

Links

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

VOLUME 35: NO. 4   APRIL 2008

Editorials

Osteonecrosis of the Jaw: New Developments in an Old Disease

A. Khan.........547→RELATED ARTICLE

Pharmacogenomics of Methotrexate in Rheumatoid Arthritis: Does Race Make a Difference?

T. Dervieux .........550→RELATED ARTICLE

The Time Has Come to Include Assessment of Radiographic Progression in Juvenile Idiopathic Arthritis Clinical Trials

A. Ravelli .........553

Articles

The Functional Variant (Asp299gly) of Toll-like Receptor 4 (TLR4) Influences TLR4-Mediated Cytokine Production in RA
   
M.F. Roelofs, M.H. Wenink, E.J.M. Toonen, et al .........558

Common Polymorphisms in the Folate Pathway Predict Efficacy of Combination Regimens Containing MTX and SSZ in Early RA
   
H.M. James, D. Gillis, P. Hissaria, et al.........562

MTX Pathway Gene Polymorphisms and Their Effects on MTX Toxicity in Caucasian and African American Patients with RA
   
P. Ranganathan, R. Culverhouse, S. Marsh, et al .........572→RELATED ARTICLE

Using Extremity MRI to Assess and Monitor Early RA: the Optimal Joint Combination to Be Scanned in Clinical Practice
   
E. Olech, J.E. Freeston, P.G. Conaghan, E.M.A. Hensor, P. Emery, D. Yocum .........580

Clinical Outcome and Imaging Changes After Intraarticular (IA) Application of Etanercept or Methylprednisolone in RA: MRI and Ultrasound-Doppler Show No Effect of IA Injections in the Wrist After 4 Weeks
   
M. Boesen, L. Boesen, K.E. Jensen, et al .........584

The Validity and Responsiveness of Generic Utility Measures in RA: A Review
   
M.J. Harrison, L.M. Davies, N.J. Bansback, M. Ingram, A.H. Anis, D.P.M. Symmons.........592

Time to Score Quantitative RA Measures: 28-Joint Count, Disease Activity Score, HAQ, MDHAQ, and RAPID Scores
   
Y. Yazici, M. Bergman, T. Pincus.........603

Comparison of Internal and External Responsiveness of the Generic MOS SF-36 with Disease-specific Measures in RA
   
M.M. Veehof, P.M. ten Klooster, E. Taal, P.L.C.M. van Riel, M.A.F.J. van de Laar.........610

Patient Decision-Making Related to Antirheumatic Drugs in RA: The Importance of Patient Trust of Physician
   
R.W. Martin, A.J. Head, J. René, et al .........618

SAP Component-DNA Complexes Are Decreased in SLE. Inverse Association with Anti-dsDNA Antibodies
   
A. Voss, E. Holm Nielsen, S.E. Svehag, P. Junker .........625

Soluble Fms-like Tyrosine Kinase Associated with Preeclampsia in Pregnancy in SLE
   
U. Qazi, C. Lam, S.A. Karumanchi, M. Petri .........631

Minimal Clinically Important Difference for 7 Measures of Fatigue in Patients with SLE
   
E.C. Goligher, J. Pouchot, R. Brant, et al .........635

Polymorphic Markers of the Fibrillin-1 Gene and SSc in European Caucasian Patients
   
J. Wipff, M. Giraud, J. Sibilia, et al.........643

Localized Scleroderma Severity Index and Global Assessments: A Pilot Study of Outcome Instruments
   
T. Arkachaisri, S. Pino .........650

The Percentage of Patients with Seronegative SpA Requiring MRI to Meet the CRA/SPARCC Guidelines for Access to Anti-TNF Treatment
   
L. Troppmann, J. Karsh.........658

Rapid and Sustained Improvement in HRQOL and Utility for 72 Weeks in Patients with AS Receiving Etanercept
   
A. Boonen, V. Patel, S. Traina, C-F. Chiou, A. Maetzel, W. Tsuji .........662

The Swedish Early Psoriatic Arthritis Register -- 2-year Followup: A Comparison with Early RA
   
U.R.C. Lindqvist, G-M. Alenius, T. Husmark, E. Theander, G. Holmström, P.T. Larsson, for the Psoriatic Arthritis Group of the Society for Rheumatology .........668

Anti-20S Proteasome Antibodies in PsA
   
I. Colmegna, B. Sainz Jr, G. Citera, J.A. Maldonado-Cocco, R.F. Garry, L.R. Espinoza.........674

Prevalence and Burden of OA: Results from a Population Survey in Norway
   
M. Grotle, K.B. Hagen, B. Natvig, F.A. Dahl, T.K. Kvien .........677

Predictors of Clinical Response to IA Hylan Injections -- A Prospective Study Using Synovial Fluid Measures, Clinical Outcomes, and MRI
   
A. Anandacoomarasamy, H. Bagga, C. Ding, D. Burkhardt, P.N. Sambrook, L.M. March.........685

Use of Oral Bisphosphonates and the Risk of Aseptic Osteonecrosis: A Nested Case-Control Study
   
M. Etminan, K. Aminzadeh, I.R. Matthew, J.M. Brophy .........691→RELATED ARTICLE

Morphology and Phenotype Expression of Types I, II, III, and X Collagen and MMP-13 of Chondrocytes Cultured from Articular Cartilage of Kashin-Beck Disease
   
W. Wang, X. Guo, J. Chen, P. Xu, M.J. Lammi.........696

Pediatric Rheumatology

Risk Factors and Longterm Outcome of JIA-Associated Uveitis in Switzerland
   
I.B. Bolt, E. Cannizzaro, R. Seger, R.K. Saurenmann .........703

Childhood Chronic Recurrent Multifocal Osteomyelitis: Pamidronate Therapy Decreases Pain and Improves Vertebral Shape
   
H. Gleeson, E. Wiltshire, J. Briody, et al .........707

Case Reports

Dissection of the Ascending Aorta in a Patient with HLA-B27 Associated AS
   
A. Juan, M. Ibáñez, J.I. Sáez de Ibarra, I. Ros, D. Crémer, J. Rosell.........713

Tophaceous CPPD Deposition Disease of the TMJ
   
J.L. Reynolds, I.R. Matthew, A. Chalmers.........717

Images in Rheumatology

Severe Back Pain in a 56-year-old Woman
 
S. Chatterjee, J.P. Schils.........722

LettersPDF Letters

Prospective Study of the Association Between NAT2 Gene Haplotypes and Severe Adverse Events with SSZ Therapy in Patients with RA
 
M. Soejima, Y. Kawaguchi, M. Hara, N. Kamatani .........724

Progressive Multifocal Leukoencephalopathy in a Minimally Immunosuppressed Patient with SLE Treated with Dapsone
 
N.I. Stahl.........725

Pseudotumoral Presentation of CPPD Crystal Deposition Disease
 
S. Brunot, T. Fabre, S. Lepreux, F. Diard, R. Massonnat, N. Sabbah, O. Hauger.........727

Corrections PDF Correction

Soluble Fms-like Tyrosine Kinase Associated with Preeclampsia in Pregnancy in Systemic Lupus Erythematosus
 
U. Qazi, C. Lam, S.A. Karumanchi, M. Petri.........729

New Onset of Crohn's Disease During Treatment of Active Ankylosing Spondylitis with Etanercept
 
I-H. Song, H. Appel, H. Haibel, C. Loddenkemper, J. Braun, J. Sieper, M. Rudwaleit .........729

Meetings in Rheumatology